Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ELCC 2018 | Goals for precision medicine in NSCLC

Silvia Novello • 11 Apr 2018
ELCC 2018
Lung Cancer Non-Small Cell Lung Cancer

Silvia Novello, MD, PhD, of San Luigi Gonzaga University Hospital, Orbassano, Italy, discusses precision medicine at the European Lung Cancer Congress (ELCC) 2018, held in Geneva, Switzerland. She explains how precision medicine relies upon molecular testing, biomarkers, and drug availability, and that the key issue to tackle is making drugs more widely available for the purposes of precision medicine across Europe.

More from Silvia Novello

1:17
The reality of implementing TKI therapies for NSCLC in Europe
Silvia Novello • 11 Apr 2018
1:23
Optimizing treatment of ALK+ NSCLC: clinical realities
Silvia Novello • 11 Apr 2018
1:48
Clinical trial data for TKIs in ALK-rearranged NSCLC
Silvia Novello • 11 Apr 2018
2:23
Exciting results from the ALEX trial
Silvia Novello • 8 Sep 2017

Related Videos

0:37
STABLE-MATES: sublobar resection vs SAbR in high-risk patients with stage I NSCLC
Clive Peedell • 18 Apr 2024
0:44
BTOG 2024: networking highlights and insights
Clive Peedell • 18 Apr 2024
0:49
Ongoing trials in thoracic radiotherapy: evaluating current role and significance
Thomas Newsom-Davis • 18 Apr 2024
4:20
Insights from BTOG 2024: advancements in TNM Staging, systematic staging, & immunotherapy strategies
Thomas Newsom-Davis • 18 Apr 2024
The content of VJOncology is intended for healthcare professionals